Rafael Holdings Inc - Class B

Research Rafael Holdings Inc - Class B (RFL) on Bullrun: market cap USD 116.47M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is USD 116.47M.

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025USD 30.00K-USD 30.52M-USD 18.93Mn/a-1.04USD 52.77MUSD 664.00KUSD 94.39M
FY2024USD 637.00K-USD 34.41M-USD 7.95M75.8%-1.45USD 2.68MUSD 2.39MUSD 82.19M
FY2023USD 279.00K-USD 1.88Mn/an/a-0.08USD 21.50MUSD 2.00MUSD 100.29M
FY2022USD 410.00K-USD 124.66M-USD 26.08M-753.4%-6.31USD 26.54MUSD 15.00MUSD 100.52M

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-08-25USD 116.47Mn/an/an/a
20252025-12-31USD 37.81Mn/an/an/a
20242024-12-31USD 40.22Mn/an/an/a
20232023-12-29USD 44.11Mn/an/an/a
20222022-12-30USD 45.03Mn/an/an/a
20212021-12-31USD 104.12Mn/an/an/a

About Rafael Holdings Inc - Class B

Rafael Holdings, Inc. primarily engages in holding interests in clinical and early-stage pharmaceutical companies, and medical devices in the United States and Israel. It operates in three segments, Healthcare, Infusion Technology, and Real Estate. The company engages in the development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells.

Related stock research

Other Real Estate stocks

Frequently asked questions

What is Rafael Holdings Inc - Class B's market cap?

Rafael Holdings Inc - Class B's market capitalization is USD 116.47M.

What does Rafael Holdings Inc - Class B do?

Rafael Holdings, Inc. primarily engages in holding interests in clinical and early-stage pharmaceutical companies, and medical devices in the United States and Israel. It operates in three segments, Healthcare, Infusion Technology, and Real Estate. The company engages in the development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells.